|
 |
ExuberaThis page contains recent news articles, when available, and an overview of Exubera but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Afresa is burdened by the ghost of Exubera, an inhaled insulin that was developed by Pfizer Inc (PFE.N). It was approved in 2006, and failed miserably. ... Reuters 2009å…¨ç?ƒè?¯ä¸šå…¼å¹¶æ½®æ¶¨ 生物è?¯è¢«çœ‹å¥½ - 06 Jan 2010 ...但是，我们也应看到辉瑞公å?¸åœ¨æ–°å“?å¼€å?‘路上的å?Žå?·ä¸?æ–，耗资高达20亿美元的å?¸å…¥å¼?èƒ°å²›ç´ Exuberaå› ä¸Žé”€å”®é¢„æœŸå·®è·?甚大而退出市场；é™?è„‚æ–°è?¯Torcetrapibå› æ‚£è€…æ»äº¡è€Œè¢«è¿« ... 生物通 Pfizer's $1.3B Esperion Loss Contained a $426M Tax Win - Jan 4, 2010 While that puts Esperion on a par with failed diabetes drug Exubera in terms of wasted Pfizer money, the deal eases Pfizer's tax situation. ... BNET New Inhaled Insulin, Provenge, Top List of 2010 Action Dates - Dec 31, 2009 ...as it attempts to overcome lingering doubts left over from Pfizer Inc.'s failure with Exubera and early termination of other similar programs. ... BioWorld Online Analyst Says MannKind's (MNKD) Has an Uncertain Future - Dec 24, 2009 They note Pfizer's Exubera, the first inhaled insulin was pulled from the market after a disappointing launch. "Although we believe Afresa is a better ... StreetInsider.com (subscription) Novo Enters Phase 1 Test of an Insulin Pill - Dec 24, 2009 Novo's experiment comes almost three years after Pfizer, Inc., withdrew Exubera, an inhaled insulin, from the market after it failed to build a following ... Diabetes Health (press release) 2009 Exits/Financings DOTY Nominee: Vertex's Milestone Sale - Dec 16, 2009 ...plush leather chairs situated in dimly lit libraries smoking apple-scented tobacco from antique Exubera inhalers to write the history of the biopharma ... The IN VIVO Blog (blog) J&J in Setback Over Antibiotic - Dec 30, 2009 California biotech Nektar Therapeutics complained that Pfizer Inc. hadn't properly marketed their jointly developed inhaled diabetes therapy, Exubera. ... Wall Street Journal Pfizer's Exubera Could Be Approved By October - Sep 9, 2005 UBS Investment Research said an experimental diabetes treatment from Pfizer (nyse: PFE - news - people ) could be launched before the end of the year after ... Forbes Pfizer 3Q profit plunges on Exubera exit - Oct 18, 2007 By Damian J. Troise, AP Business Writer. NEW YORK — Pfizer Inc. reported a 77 percent drop in third-quarter profit Thursday as the world's largest ... USA Today Pfizer's Exubera Flop - Oct 18, 2007 Needle-free insulin was supposed to be the next big thing in drugs. Turns out patients aren't interested—it'll cost Pfizer $2.8 billion. by Arlene Weintraub ... BusinessWeek US Regulators Approve Insulin in Inhaled Form - Jan 28, 2006 Analysts predict that the therapy, called Exubera and sold by Pfizer, will be popular, ... Pfizer said it planned to begin selling Exubera this summer. ... New York Times Pfizer warns of lung cancer with inhaled insulin - Apr 9, 2008 The lung-cancer revelation dealt a final setback to Exubera, which held the ... Instead, Exubera has been a commercial flop that has sullied the inhaled ... Reuters UK Pfizer, Sanofi End Exubera Pact - Jan 13, 2006 By Robert Steyer 01/13/06 - 02:37 PM EST. Pfizer has agreed to pay $1.3 billion to Sanofi-Aventis (SNY Quote) for the French company's share of their ... TheStreet.com - TheStreet.com (subscription) Nektar gets $135 million payment as Pfizer turns over Exubera - … - Nov 13, 2007 A month ago, Pfizer announced it would cease marketing Exubera due to poor sales. ... Despite high hopes from the diabetes community, Exubera never gained ... MarketWatch Exubera-nce in the Insulin Market - Jun 10, 2005 By Robert Steyer. In your typical business environment, there's little love lost among competitors. However, for the many companies developing inhaled ... TheStreet.com - TheStreet.com (subscription) Judge Won't Stop Exubera Sales - Dec 14, 2006 By LARRY NEUMEISTER, AP Writer. NEW YORK — The public's need for a "new and less invasive treatment for diabetes" will keep Pfizer's inhalable insulin ... FOXNews The drug Exubera looks like an expensive flop for Pfizer - Apr 10, 2007 By Alex Berenson. NEW YORK — Exubera, the first and so far only commercially available inhaled-insulin diabetes treatment, is on the verge of turning into ... New York Times FDA decision on Exubera still pending - Jan. 27, 2006 - Jan 27, 2006 Federal regulatory agency hasn't completed review of diabetes treatment, despite Pfizer CEO's comments on TV. NEW YORK (CNNMoney.com) - Exubera, ... CNNMoney.com Exubera Getting More Review - Oct 28, 2005 Pfizer (PFE Quote) said Friday that the Food and Drug Administration will need an extra three months to review its application for the inhaled insulin ... TheStreet.com - TheStreet.com (subscription) West settles with Nektar over Exubera - Feb 13, 2008 LIONVILLE, Pa. (AP) - West Pharmaceutical Services Inc., which makes parts for vials and syringes, said Wednesday it has negotiated with Nektar Therapeutics ... Forbes Pfizer's decision to halt Exubera sales seen as blow to Indian arm - Oct 23, 2007 Drug industry analysts say that Pfizer Inc.'s decision to abandon its inhaled insulin product Exubera will be a major blow to the ongoing portfolio ... Livemint Sanofi-Aventis, Pfizer say studies demonstrate Exubera effectiveness - Jun 14, 2005 PARIS (AFX) - Sanofi-Aventis SA and Pfizer Inc said results from three two-year studies of their jointly developed Exubera insulin treatment demonstrated ... Forbes Irrational Exubera-nce for Pfizer? - Feb 15, 2006 The outfit's inhaled insulin may not be the revolutionary treatment many expect. If that proves to be the case, expect insurance companies to balk ... BusinessWeek Pfizer slumps as diabetics spurn Exubera - Oct 19, 2007 Pfizer, the world's largest pharmaceuticals company, reported a 77 per cent plunge in profits yesterday prompted by its decision to scrap Exubera, ... Times Online No Irrational Exuberance for Exubera - Sep 19, 2006 By Michael Latwis. September has brought the long-awaited market launch of Nektar Therapeutics' (NKTR) inhaled insulin treatment, Exubera, by marketing and ... TheStreet.com - TheStreet.com (subscription) Exubera Gets Good Marks | Biotech/Pharmaceuticals | Financial... - Oct 13, 2005 By TSC Staff 10/13/05 - 03:30 PM EDT. Pfizer (PFE Quote) said a committee of the European Medicines Agency issued a positive opinion recommending approval ... TheStreet.com - TheStreet.com (subscription) From Pfizer, Irrational Exubera? - Jul 17, 2006 Janet Ruhl may be Pfizer Inc.'s (PFE ) worst nightmare. Ruhl, who injects a small amount of insulin each day to control her diabetes, has been dissing ... BusinessWeek Some Doctors Balk at Inhaled Insulin - Mar 21, 2007 Exubera, a powdered form inhaled through a special device, ... Observers fear Exubera won't fare much better as Pfizer expands the sales effort to primary ... Washington Post Exubera buyout a matter of price: Pfizer - Nov 7, 2005 NEW YORK (Reuters) - Pfizer Inc. (PFE.N: Quote, Profile, Research, Stock Buzz) said on Monday it was negotiating to buy its partner Sanofi-Aventis SA (SASY. ... Reuters Exubera Demonstrated Pulmonary Safety with Blood Sugar Control in … - Jun 23, 2007 CHICAGO -- Results from three-year interim analyses of two ongoing long-term clinical trials showed that small mean declines in lung function in diabetes ... Free with registration - Business Wire - AccessMyLibrary.com Pfizer's Chantix Woes Bash Blockbuster Hopes - Jun 24, 2008 It started marketing Exubera -- hailed as a breakthrough for diabetes patients ... Six months after Exubera hit the market, however, critics were already ... TheStreet.com - TheStreet.com (subscription) Pfizer Postpones Exubera Launch - Jul 20, 2006 By Robert Steyer 07/20/06 - 05:49 PM EDT. Pfizer (PFE Quote) says it will delay the launch of its inhaled insulin Exubera until September, several weeks ... TheStreet.com - TheStreet.com (subscription) Good news, bad news for Mannkind's inhaled insulin system - Sep 17, 2008 Pfizer stopped selling its Exubera powder in October after abysmal sales, ... Several analysts said they felt Technosphere was superior to Exubera in design ... Los Angeles Times Nektar Can't Shake Tempered Exubera - May 29, 2007 If you think the stumbling start of inhaled-insulin treatment Exubera has hurt Pfizer(PFE Quote), then look at what has happened to its partner, ... TheStreet.com - TheStreet.com (subscription) EU seeks lung cancer caution on Pfizer's Exubera - Jun 17, 2008 LONDON, June 17 (Reuters) - The European Medicines Agency said on Tuesday that information about lung cancer should be added to the label for Pfizer Inc's ... Reuters Exubera Success May Hinge on Usability - Jun 30, 2006 By Robert Steyer. At the recent annual scientific meeting of the American Diabetes Association, the Pfizer (PFE - commentary - Cramer's Take) booth was ... TheStreet.com - TheStreet.com (subscription) Exubera-nce in the Insulin Market - May 19, 2005 At least in the US, Forman's thesis is that sales of inhaled insulin won't necessarily come at the expense of injected insulin. Last year in the US, ... TheStreet.com - TheStreet.com (subscription) Weak Sales Prompt Pfizer to Cancel Diabetes Drug - Oct 19, 2007 Pfizer said yesterday that it would stop selling Exubera, its inhaled insulin, ... But Pfizer said it would not try to develop a replacement for Exubera, ... New York Times Novo Nordisk settles Exubera patent lawsuit with Pfizer - Dec 10, 2007 SAN FRANCISCO (Thomson Financial) - Novo Nordisk A/S said late Monday it has settled a lawsuit against Pfizer Inc. that claimed the New York-based ... Forbes Nektar to pay partners up to $38.4M for Exubera costs - Feb 21, 2008 Nektar Therapeutics Inc. will pay two suppliers of inhalers for its Exubera inhaled insulin drug up to $38.4 million for costs and expenses due to Pfizer ... Bizjournals.com Nektar Reports Pfizer Announcement of New Exubera Data; New Data … - Jun 10, 2006 ...-- Principal Investigator: "Exubera is a valuable new option that could improve earlier acceptance of insulin among people with type 2 diabetes, ... Genetic Engineering News - Genetic Engineering News (press release) Inhaled Insulin Is Effective, Pfizer Reports - Jun 15, 2005 Pfizer, the drug maker, said yesterday that Exubera, an inhaled insulin powder that ... Two other studies covering 304 patients showed that Exubera was well ... New York Times Alkermes says Lilly to drop out of insulin program - Mar 7, 2008 N: Quote, Profile, Research) abandoned Exubera, the first inhaled form of insulin, ... But Exubera had dismal sales because patients were turned off by the ... Reuters UK Pfizer's outlook cut to negative after a writedown of Exubera assets ... - Oct 19, 2007 ...ratings to negative from stable after the pharma company reported a 2.8 bln usd write-down on discontinuing with its inhaled insulin treatment Exubera. ... Forbes Exubera: Inhaled insulin approved by FDA - Jul 24, 2006 What happened? The Food and Drug Administration (FDA) has approved Exubera, the first inhaled insulin, for treatment of adults with type 1 or type 2 ... CNN Drug stocks slip; Mannkind dips - Apr 14, 2008 Pfizer said a few months ago it intended to stop selling Exubera due to poor sales. Nektar shares, which were also badly hurt by the Exubera news, ... MarketWatch Exubera, first inhaled insulin, wins US FDA Advisory Panel's support - Sep 12, 2005 Washington.– Exubera, if it comes onto the market, could mean no more injections during the day for millions of diabetes patients. ... Dominican Today Novo Halts Inhaled Insulin, Citing Lack of Benefit - Jan 14, 2008 Pfizer Inc. discontinued its Exubera inhaled insulin in October 2007 after patients ... Doctors and patients said the Exubera inhaler, about the size of an ... Bloomberg Pfizer Seeks Pricing Perfection - Jun 23, 2006 She frets that Exubera could be affected by "a tough reimbursement ... She predicts that Exubera will record a little more than $1.1 billion in sales in ... TheStreet.com - TheStreet.com (subscription) Diabetes fears as inhaled insulin discontinued - Jan 14, 2008 Exubera was launched in the UK in August 2006. ... A spokesman for Pfizer said: “Despite our best efforts, Exubera has not gained the acceptance of patients ... Telegraph.co.uk Atlanta health, diet and fitness news | ajc.com - Mar 2, 2005 Exubera is a dry powder form of insulin that's inhaled into the lungs prior to ... Exubera has been studied in more than 3500 patients, the companies said. ... Atlanta Journal Constitution Pfizer 1st-quarter profit falls sharply - Apr 20, 2007 Sales of the inhalable insulin Exubera, however, were "disappointing," the company said, not specifying dollar amounts. The results were well above Wall ... msnbc.com Inhaled insulin's cost may take breath away - Feb 2, 2006 Pfizer will not yet disclose a price for Exubera, which the company expects ... Exubera is expected to carry a price tag of $4 a day in the United States, ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Before .You .Start Exubera . - Jul 22, 2007 Are pregnant or plan to become pregnant. EXUBERA has not been tested enough in pregnant women . i Are breast-feeding: Insulin can pass into breast milk and ... Herald-Tribune - Google News Archive Inhaled insulin flops, but field may hold promise - Apr 13, 2008 Pfizer had already decided last year to stop marketing Exubera, ... In addition, Exubera has always been associated with slight impairment of lung function, ... Reuters Experts to vote on inhalable insulin from Pfizer, Nektar. - Aug. 30,... - Aug 30, 2005 8 on Exubera, an inhalable form of insulin developed by Pfizer Inc. (unchanged at ... Many analysts consider Exubera a convenient product and a potential ... CNNMoney.com Nektar says initial supplies of Pfizer's Exubera to be available in... - Jul 20, 2006 LONDON (AFX) - Biopharmaceutical company Nektar Therapeutics said initial supplies of Pfizer Inc's Exubera will be available across the US beginning in ... Forbes Drug maker undeterred by doubts - Jan 18, 2008 In October, Pfizer Inc. shelved its Exubera inhaled insulin product, ... Doctors and patients said that Exubera was bulkier than injection needles and ... Boston Globe Study: Inhaled insulin works for type 1 - Jun 28, 2005 The insulin used in the study is Exubera, being developed by Pfizer and Sanofi ... Exubera is now under Food and Drug Administration review and could be ... USA Today … third-quarter earnings down 76 pct on charges for scrapping Exubera... - Oct 18, 2007 Meanwhile, we made an important decision regarding Exubera, a product for which ... 'Despite our best efforts, Exubera has failed to gain the acceptance of ... Forbes Inhaled insulin worries sink MannKind - Mar 10, 2008 In October, Pfizer Inc. pulled Exubera inhaled insulin from the market citing poor sales. Though effective, physicians faulted the cumbersome design as a ... Boston Globe Can inhaled insulin improve glycemic control of type 2 diabetes? - Dec 1, 2005 To assess the efficacy and safety of the inhaled insulin EXUBERA ® (Pfizer ... Participants were randomly allocated to one of the following: Exubera ® plus ... Nature.com Nektar to seek new partner for Exubera - Oct 25, 2007 Nektar Therapeutics Inc., hit by Pfizer Inc.'s decision last week to dump the inhaled insulin product Exubera, said it may seek a new partner and is ... Bizjournals.com Exubera Effective in Diabetes Patients who Have Respiratory Infections... - Sep 14, 2006 ...- Investigator: 'Patients Taking Exubera are No More Likely to Develop a Respiratory Infection Than Patients Using Injectable Insulin.' ... Free with registration - PR Newswire - AccessMyLibrary.com Inhaled Insulin Study Shows Pfizer Drug Patients Gain Less Weight. - Jun 12, 2006 Exubera was recently approved by the Food and Drug Administration and the ... In the type 2 study, patients on Exubera improved or sustained their blood ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Alkermes cuts jobs, closes facility, takes charges - Mar 19, 2008 N) decision to abandon Exubera, the first approved inhaled form of insulin ... Exubera sales failed to take off because patients disliked the device used to ... Reuters Mannkind Corp. bets on inhaled insulin - Nov 17, 2007 I was taking four shots a day and after seeing an Exubera advertisement on TV ... After sixty years of dealing with this disease I feel that Exubera is one ... earthtimes.org Betting an Estate on Inhaled Insulin - Nov 16, 2007 And Nektar Therapeutics, which licensed Exubera to Pfizer, is now looking for a new partner in an effort to keep the product on the market. ... New York Times Q1 2006 Nektar Therapeutics Earnings Conference Call - Final. - May 10, 2006 Over the next 3 to 4 years, our growth will be largely driven by Exubera sales, ... While most investors are currently focused on the Exubera opportunity, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Waiting to inhale - Nov 30, 2007 He has hailed the potential of Exubera, the world's first inhaled insulin ... When Pfizer suddenly dumped Exubera in mid-October -- retreating after its ... Bizjournals.com Breathing Life Into an Idea; Nektar has been working on the inhaled-... - Sep 23, 2005 Because Exubera is licensed to Pfizer, [Nektar] won't make a killing on the drug. ... The drug, called Exubera, could reduce or eliminate the need for ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Pfizer May Double Outsourcing - Dec 1, 2007 Pfizer saw a big setback in its pipeline recently when it pulled Exubera, ... Once viewed as a potential blockbuster, Exubera was approved in January, ... Wall Street Journal New drugs expand treatment of diabetes - Jun 22, 2006 Another, Exubera, an inhalable form of insulin, has been approved and will reach pharmacies next month. The other two, Galvus and Januvia, both taken as ... $2.95 - Fort Worth Star-Telegram - NewsBank Exubera Success May Hinge on Usability - Jun 30, 2006 The product comes with an instructional manual, details of which are posted at www.exubera.com in a PDF file with 44 pages of large type, ... TheStreet.com - TheStreet.com (subscription) Inhaled insulin a boon to diabetics, Terre Haute. - Mar 21, 2006 Called Exubera, the inhaled insulin took 15 years to develop. ... Exubera brings luster to Pfizer's Terre Haute operations, which in the past turned out ... Free with registration - Indianapolis Star - AccessMyLibrary.com Diabetes inhaler rejected for NHS - Apr 19, 2006 The drug, Exubera, is designed to offer adults with diabetes an ... Exubera for Type 1 and 2 diabetes costs £1100 per person per year but patients would ... BBC News Pfizer's inhaled insulin fails to impress - Mar 26, 2007 Dr. Robert Fafalak discusses the medication Exubera in his New York office ... Exubera, a powder inhaled through a special device, was introduced last year. ... East Valley Tribune Inhaled Insulin Fails to Impress - Mar 31, 2007 Exubera, a powdered form of insulin inhaled through a special device, ... Observers fear Exubera won't fare much better as Pfizer expands the sales effort ... Press-Enterprise Inhaled insulin given UK launch - Aug 4, 2006 But availability of Exubera on the NHS has been reserved for people with a proven ... Exubera for Type 1 and 2 diabetes costs £1100 per person per year but ... BBC News MannKind says struggling to find partner; shares fall - Aug 3, 2007 Henry said the disappointing launch of TI's competitor product Exubera, an inhaled insulin product from Pfizer (PFE.N: Quote, Profile, Research), ... Reuters UK Loss Widens for Nektar - Feb 28, 2006 The Food and Drug Administration approved Exubera on Jan. 27, one day after the European Union ... Pfizer has said Exubera will be available by midyear. ... TheStreet.com - TheStreet.com (subscription) Pfizer's Exuberant Ad Rollout - Jul 24, 2007 Pfizer has launched a huge marketing campaign for slow-selling Exubera. ... When Pfizer (PFE) introduced Exubera, the first ever inhalable insulin product ... BusinessWeek MannKind shares rise after presentations on technosphere insulin - May 15, 2008 Unlike Exubera, for instance, there are also no complicated meal-time titrations ... Other inhaled insulins, including Exubera, cause some lung degradation, ... Forbes Article: FDA approves inhaled insulin for diabetics. - Chicago... - Jan 27, 2006 The FDA approved Exubera for both type 1 and type 2 diabetes, calling the new ... NOW, THE FDA HAS APPROVED EXUBERA, THE FIRST INHALED AND NON-INJECTABLE ... Pay-Per-View - Chicago Tribune - HighBeam Research Pfizer Trims Guidance - Apr 20, 2007 ..."While we remain convinced that Exubera offers substantial benefit for diabetic ... "We remain very committed" to Exubera, said Ian Read, who runs Pfizer's ... TheStreet.com - TheStreet.com (subscription) … the Sanofi-Aventis Worldwide Rights to Exubera(R) (Inhaled Human … - Jan 12, 2006 There will be no change to the Exubera contractual terms between Nektar and Pfizer. Nektar developed the inhalers and the powdered insulin formulation for ... RedOrbit New diabetes medicines are coming on the market, and manufacturers … - Jul 14, 2006 The annual cost of new treatments like Byetta and Exubera has been estimated between ... The wholesale price of Exubera ranges from $3.73 to $5 per day, ... Pay-Per-View - Newsday - ProQuest Archiver UK small caps flat in quiet midday trade; Instore gains after cutting... - Oct 19, 2007 Also down was Consort Medical, 15 lower at 630, following news late yesterday Pfizer's decision to exit the Exubera insulin product and the closure of the ... Forbes Exubera Hailed as Innovation In Prestigious European and American … - Sep 12, 2006 ...- WSJ/Professor Pedro Nueno: "The drug could encourage diabetes sufferers to get treatment earlier and more often. This has such a tremendous advantage for ... ots.at Euroshares weak midday ahead of key inflation data; broker downgrades... - Jan 13, 2006 Oddo Securities said the price achieved for Exubera is in line with its expectations and added that the sale of the rights is good news for Sanofi-Aventis ... Forbes Exubera Approved Despite Initial Lung Function Concerns - Feb 9, 2006 Feb. 9, 2006 -- Despite initial concerns regarding lung function, the US Food and Drug Administration (FDA) approved Pfizer's inhaled insulin Exubera for ... Medscape … Pfizer's marketing fizzle with Exubera?: EXUBERA, THE FIRST... - Aug 31, 2007 Did Pfizer's marketing fizzle with Exubera?: EXUBERA, THE FIRST INHALED VERSION OF INSULIN, WAS EXPECTED TO BE A DYNAMITE DRUG. Pay-Per-View - San Jose Mercury News - HighBeam Research PHARMACEUTICALS; Small rival takes deep breath; Pfizer flopped with … - Oct 30, 2007 The high-profile failure of Pfizer Inc.'s Exubera is considered one of the biggest flops ... Before Exubera arrived on the market this year and sold poorly, ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Diabetic inhaler a boon for Bespak - Jan 20, 2005 Bespak makes the inhalation device for Exubera, a new drug from Pfizer that allows ... Exubera could improve Bespak's sales by £30m a year, analysts say. Telegraph.co.uk Nektar Convinces Bayer To Inhale - Aug 6, 2007 The company that brought us the infamous Exubera inhaled insulin device - you ... Exubera racked up just $4 million in sales in the second quarter and the ... Pharmalot Judge allows sale of Pfizer diabetes drug - Rival loses round in... - Dec 15, 2006 ..."If they choose to change from injections to Exubera, it's as effective," Aristide said. She said Exubera was being rolled out slowly to ensure physicians, ... Pay-Per-View - Star-Ledger - Factiva, from Dow Jones MannKind Phase 3 inhaled insulin studies meet goal - Dec 4, 2008 Exubera, Pfizer's inhaled insulin product, was withdrawn from the US market in 2007 due to weak demand. MannKind shares were up 9 cents, or 3.1 percent, ... Reuters French Sanofi-Aventis posts 53.6 percent profit rise in first quarter - May 5, 2006 Sanofi-Aventis said that the sale of its Exubera patent to the US group Pfizer ... Exubera, the product of a joint development program between Aventis and ... æ–°å?Žç½‘ Be Kind to MannKind - Dec 5, 2008 After Exubera -- Nektar Therapeutics (Nasdaq: NKTR) and Pfizer's (NYSE: PFE) inhaled insulin product -- was deemed a marketing failure and Novo Nordisk ... fool.com QDose closes in on Exubera - Aug 7, 2007 By Anna Lewcock, 07-Aug-2007. An improved inhalable insulin product developed by collaborating UK and US firms has just completed a glucose clamp study in ... In-PharmaTechnologist.com Lilly CEO: Zyprexa 2007 seen flat from 2006 - MarketWatch - Mar 14, 2007 ..."We're watching, very closely, what's happening with our competitor Pfizer, which has launched Exubera, and so far they haven't done very well. ... MarketWatch Long-Term Safety of Inhaled Insulin Needs More Study - Nov 7, 2006 It evaluated Exubera, Pfizer Inc.'s inhaled insulin delivery system. ... In January 2006, Exubera became the first new insulin delivery option to be ... FOXNews Bespak to cut jobs as Exubera prospect falls short - Jun 28, 2007 By Emilie Reymond, 28-Jun-2007. Bespak, one of the two contract manufacturers of Pfizer's inhaled insulin Exubera, has announced it will cut a "significant" ... In-PharmaTechnologist.com Pfizer and Other Drug Makers Report Higher Profits - Oct 20, 2006 Exubera, which analysts had predicted would be a blockbuster, now appears to be running into widespread resistance from doctors concerned about its ... New York Times Merck To Showcase Diabetes Treatment Data - Jun 8, 2006 Neither product will likely meaningfully impact the companies' stocks, the analyst said, though there could be some pre-launch buzz surrounding Exubera at ... Forbes Companies: Corporate Profile - Nektar welcomes place in the spotlight.... - May 22, 2006 Exubera has catapulted Nektar Therapeutics to a new level - one for which ... The day the Food and Drug Administration (FDA) approved Exubera was a great ... Free with registration - PR Week - AccessMyLibrary.com Novo Nordisk Sales Climb - Jan 27, 2006 In addition, the Food and Drug Administration may rule today on Exubera. Novo Nordisk's development of inhaled insulin has proceeded in fits and starts, ... TheStreet.com - TheStreet.com (subscription) |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |